Skip to main content
. Author manuscript; available in PMC: 2014 Apr 24.
Published in final edited form as: Expert Opin Drug Discov. 2013 Apr 18;8(6):621–640. doi: 10.1517/17460441.2013.788496

Scheme 1.

Scheme 1

Examples of CHK1 inhibitors generated using SBDD from initial hit to late stage leads or clinical candidates. a The structure of 25 has been drawn as it appears in the graphical abstract of the reference [51] which differs from the representation in the body of the text.